[GAMUDA] QoQ TTM Result on 30-Apr-2012 [#3]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
28-Jun-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2012
Quarter
30-Apr-2012 [#3]
Profit Trend
QoQ- 4.18%
YoY- 38.12%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
TTM Result
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
Revenue 2,629,125 2,898,272 3,087,003 2,927,795 2,843,136 2,681,000 2,673,208 -1.09%
PBT 733,228 734,291 728,210 702,599 664,940 601,994 544,524 21.83%
Tax -139,485 -154,681 -162,219 -150,910 -138,026 -125,415 -111,579 15.96%
NP 593,743 579,610 565,991 551,689 526,914 476,579 432,945 23.31%
-
NP to SH 580,841 560,424 547,305 533,026 511,646 469,198 425,411 22.95%
-
Tax Rate 19.02% 21.07% 22.28% 21.48% 20.76% 20.83% 20.49% -
Total Cost 2,035,382 2,318,662 2,521,012 2,376,106 2,316,222 2,204,421 2,240,263 -6.16%
-
Net Worth 4,235,195 4,182,122 4,052,884 3,984,736 3,825,379 3,818,879 3,691,757 9.54%
Dividend
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
Div 249,362 249,362 248,378 248,378 247,276 247,276 245,534 1.03%
Div Payout % 42.93% 44.50% 45.38% 46.60% 48.33% 52.70% 57.72% -
Equity
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
Net Worth 4,235,195 4,182,122 4,052,884 3,984,736 3,825,379 3,818,879 3,691,757 9.54%
NOSH 2,086,303 2,080,658 2,078,402 2,075,383 2,067,772 2,064,259 2,062,434 0.76%
Ratio Analysis
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
NP Margin 22.58% 20.00% 18.33% 18.84% 18.53% 17.78% 16.20% -
ROE 13.71% 13.40% 13.50% 13.38% 13.38% 12.29% 11.52% -
Per Share
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
RPS 126.02 139.30 148.53 141.07 137.50 129.88 129.61 -1.84%
EPS 27.84 26.93 26.33 25.68 24.74 22.73 20.63 22.00%
DPS 12.00 12.00 12.00 12.00 12.00 12.00 12.00 0.00%
NAPS 2.03 2.01 1.95 1.92 1.85 1.85 1.79 8.70%
Adjusted Per Share Value based on latest NOSH - 2,075,383
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
RPS 93.18 102.71 109.40 103.76 100.76 95.01 94.74 -1.09%
EPS 20.59 19.86 19.40 18.89 18.13 16.63 15.08 22.95%
DPS 8.84 8.84 8.80 8.80 8.76 8.76 8.70 1.06%
NAPS 1.501 1.4821 1.4363 1.4122 1.3557 1.3534 1.3084 9.54%
Price Multiplier on Financial Quarter End Date
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
Date 31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 29/07/11 -
Price 3.72 3.61 3.51 3.56 3.70 3.40 3.69 -
P/RPS 2.95 2.59 2.36 2.52 2.69 2.62 2.85 2.31%
P/EPS 13.36 13.40 13.33 13.86 14.95 14.96 17.89 -17.61%
EY 7.48 7.46 7.50 7.21 6.69 6.69 5.59 21.32%
DY 3.23 3.32 3.42 3.37 3.24 3.53 3.25 -0.40%
P/NAPS 1.83 1.80 1.80 1.85 2.00 1.84 2.06 -7.55%
Price Multiplier on Announcement Date
31/01/13 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 CAGR
Date 28/03/13 13/12/12 27/09/12 28/06/12 28/03/12 16/12/11 29/09/11 -
Price 4.13 3.64 3.40 3.46 3.60 3.00 2.87 -
P/RPS 3.28 2.61 2.29 2.45 2.62 2.31 2.21 29.95%
P/EPS 14.83 13.51 12.91 13.47 14.55 13.20 13.91 4.34%
EY 6.74 7.40 7.74 7.42 6.87 7.58 7.19 -4.19%
DY 2.91 3.30 3.53 3.47 3.33 4.00 4.18 -21.36%
P/NAPS 2.03 1.81 1.74 1.80 1.95 1.62 1.60 17.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment